BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37186766)

  • 21. Regional citrate anticoagulation for replacement therapy in patients with liver failure: A systematic review and meta-analysis.
    Peng B; Lu J; Guo H; Liu J; Li A
    Front Nutr; 2023; 10():1031796. PubMed ID: 36875829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional citrate anticoagulation vs systemic heparin anticoagulation for double-filtration plasmapheresis.
    Teh SP; Ho QY; Kee YST; Thangaraju S; Tan RY; Teo SH; Tan HK; Tan CS; Choong HLL; Ng LC; Abdul Rahman M; Lim AEL; Kaushik M
    J Clin Apher; 2023 Feb; 38(1):16-23. PubMed ID: 36197100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Citric Acid and Heparin Anticoagulation in Patients with Septic Acute Kidney Injury Undergoing Continuous Renal Replacement Therapy: A Meta-Analysis.
    Lin S; Xiao M; Cai Q; Lin Y; Yao J; Sun X; Huang J
    Altern Ther Health Med; 2023 Nov; 29(8):421-425. PubMed ID: 37652410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K; Srivaths PR; Tal L; Watson MN; Riley AA; Himes RW; Desai MS; Braun MC; Akcan Arikan A
    PLoS One; 2017; 12(8):e0182134. PubMed ID: 28792509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.
    Brunoni B; Zadek F; Mulazzani F; Verza G; Marrazzo F; Spina S; Protti A; Fumagalli R; Langer T
    Blood Purif; 2023; 52(9-10):802-811. PubMed ID: 37673054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy.
    Warnar C; Faber E; Katinakis PA; Schermer T; Spronk PE
    J Clin Monit Comput; 2022 Jun; 36(3):871-877. PubMed ID: 33991270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.
    Bai M; Zhou M; He L; Ma F; Li Y; Yu Y; Wang P; Li L; Jing R; Zhao L; Sun S
    Intensive Care Med; 2015 Dec; 41(12):2098-110. PubMed ID: 26482411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care.
    Doidge JC; Gould DW; Sadique Z; Borthwick M; Hatch RA; Caskey FJ; Forni L; Lawrence RF; MacEwan C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
    J Crit Care; 2023 Apr; 74():154218. PubMed ID: 36494257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation in renal replacement therapies: Why heparin should be abandoned in critical ill patients?
    Musalem P; Pedreros-Rosales C; Müller-Ortiz H
    Int Urol Nephrol; 2024 Apr; 56(4):1383-1393. PubMed ID: 37755609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRRT Regional Anticoagulation Using Citrate in the Liver Failure and Liver Transplant Population.
    Wonnacott R; Josephs B; Jamieson J
    Crit Care Nurs Q; 2016; 39(3):241-51. PubMed ID: 27254640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.